Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,460.00p
   
  • Change Today:
    -25.00p
  • 52 Week High: 2,715.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.54m
  • Volume: 67,699
  • Market Cap: £1,636.82m
  • RiskGrade: 128
  • Beta: 1.29

Key dates

Dividend  
Expected XD Date (Final) 06-Nov-2025
Expected Pay Date (Final) 05-Dec-2025
   
Meetings  
AGM 19-Nov-2025
EGM n/a
GMs n/a
   
Announcements  
Trading announcement 15-Jul-2025
IMSs 15-May-2014
Drilling Report n/a
   
Results  
Final results 04-Sep-2025
Interim results 27-Feb-2025
Q1 Results n/a
Q2 Results n/a
Q3 Results n/a
Q4 Results n/a
Annual Report 14-Oct-2024
   
Year End 30-Jun-2026

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,460.00p
Change Today -25.00p
% Change -1.01 %
52 Week High 2,715.00
52 Week Low 1,424.00
Volume 67,699
Shares Issued 66.54m
Market Cap £1,636.82m
Beta 1.29
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average92.49% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average78.22% above the market average
90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average90.91% above the sector average
Income
98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average98.6% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average91.76% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 06-Nov-25 06-Mar-25
Paid 05-Dec-25 04-Apr-25
Amount 21.70p 10.30p

Trades for 31-Oct-2025

Time Volume / Share Price
16:58 6,914 @ 2,460.00p
16:39 246 @ 2,460.00p
16:37 8,552 @ 2,460.00p
16:35 97 @ 2,460.00p
16:35 232 @ 2,460.00p

Genus Key Personnel

CEO Jorgen Kokke
CFO Andy Russell

Top of Page